Citadel Advisors
ERAS icon

Citadel Advisors’s Erasca ERAS Stock Holding History

Citadel Advisors’s Portfolio ERAS Stock Details ERAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.74M Sell
94,741
-403,640
-81% -$5.77M ﹤0.01% 6889
2026
Q1 		$8.06M Sell
498,381
-531,964
-52% -$6.29M ﹤0.01% 3569
2025
Q4 		$3.83M Buy
1,030,345
+688,546
+201% +$1.94M ﹤0.01% 4742
2025
Q3 		$745K Buy
+341,799
New +$544K ﹤0.01% 8195
2025
Q2 		– Sell
-402
Closed -$538 – 13197
2025
Q1 		$551 Sell
402
-4,287,967
-100% -$7.36M ﹤0.01% 14246
2024
Q4 		$10.8M Sell
4,288,369
-27,304
-0.6% -$74.9K ﹤0.01% 2899
2024
Q3 		$11.8M Buy
4,315,673
+1,022,302
+31% +$2.88M ﹤0.01% 2675
2024
Q2 		$7.77M Buy
3,293,371
+2,456,057
+293% +$5.3M ﹤0.01% 3115
2024
Q1 		$1.72M Sell
837,314
-1,310,280
-61% -$2.62M ﹤0.01% 5817
2023
Q4 		$4.57M Buy
2,147,594
+384,949
+22% +$812K ﹤0.01% 3924
2023
Q3 		$3.47M Buy
1,762,645
+465,813
+36% +$1.19M ﹤0.01% 4234
2023
Q2 		$3.58M Sell
1,296,832
-2,033,736
-61% -$5.79M ﹤0.01% 4166
2023
Q1 		$10M Buy
3,330,568
+2,471,895
+288% +$8.99M ﹤0.01% 2813
2022
Q4 		$3.7M Buy
858,673
+744,039
+649% +$5.04M ﹤0.01% 4390
2022
Q3 		$894K Buy
114,634
+23,524
+26% +$189K ﹤0.01% 7233
2022
Q2 		$507K Buy
91,110
+44,648
+96% +$292K ﹤0.01% 8610
2022
Q1 		$400K Buy
+46,462
New +$538K ﹤0.01% 9897
2021
Q4 		– Sell
-10,968
Closed -$233K – 14026
2021
Q3 		$233K Buy
+10,968
New +$226K ﹤0.01% 11634

Other funds holding ERAS

FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Citadel Advisors's ERAS Position: Q2 2026 in Review

Citadel Advisors reduced its Erasca (ERAS) stake by 81% in Q2 2026, selling an estimated $5.77M and leaving 94,741 shares worth $1.74M. The position accounts for ﹤0.01% of the portfolio, ranked #6889.

Citadel Advisors first reported a position in ERAS in Q3 2021 and has held it in 18 quarters since. The position peaked at $11.8M in Q3 2024. 257 funds tracked by Wall St. Rank hold ERAS as of Q2 2026.

  • Citadel Advisors held 94,741 shares of Erasca worth $1.74M as of Q2 2026.
  • Citadel Advisors sold 403,640 Erasca shares in Q2 2026, an estimated $5.77M.
  • Erasca made up ﹤0.01% of Citadel Advisors's portfolio in Q2 2026, its #6889 holding.
  • Citadel Advisors first reported a position in Erasca in Q3 2021 and has held it in 18 quarters since.
  • Citadel Advisors's Erasca position peaked at $11.8M in Q3 2024.
  • 257 funds tracked by Wall St. Rank held Erasca as of Q2 2026.

Based on Citadel Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.